This article is the fourth in a series. If you missed the background:
- Part 1: The Epstein Files – How Pandemics Became a Financial Product
- Part 2: October 2019 – The EU Practiced Suppressing the Lab Theory
- Part 3: Kostaive – The Self-Amplifying mRNA Vaccine Without Safety Review
If you know all three, you now see the complete picture.
2011: “More money for vaccines” #
We documented this in Part 1. Jeffrey Epstein, already a convicted sex offender, was advising JPMorgan and Bill Gates on the construction of a billion-dollar fund. In an internal email he stated the objective:
“A silo based proposal that will get Bill more money for vaccines.”
Vaccines as a capital investment strategy. Healthy people as a market. Parametric reinsurance products that automatically pay out when a pandemic is declared.
That was 2011.
2017: CEPI – The Tool Is Built #
The Coalition for Epidemic Preparedness Innovations (CEPI) was founded in 2017 — in cooperation with the World Economic Forum, co-funded by the Bill & Melinda Gates Foundation.
The explicitly stated goal, documented in the Epstein Files and publicly communicated: reduce vaccine development from typically 10 years to under 1 year.
This was not a scientific promise. It was a business plan.
Because whoever can develop and approve vaccines in 12 months can respond to every new “pandemic” — and earn billions with each cycle.
2022: $300 Million Gates → CEPI #
In January 2022 — in the middle of the COVID pandemic, while mRNA vaccines were already being administered worldwide — the Bill & Melinda Gates Foundation and the Wellcome Trust together pledged $300 million to CEPI.
Not for healthcare. For the next vaccine platform.
2023: CEPI Funds sa-mRNA for “Disease X” #
In August 2023, CEPI awarded grants for the development of self-amplifying mRNA platforms — explicitly for use against “Disease X”, the as-yet unknown next pathogen.
$3.6 million for sa-mRNA technology alone. In parallel, further CEPI projects are running for “trans-amplifying mRNA” — the next stage beyond sa-mRNA.
The WEF used “Disease X” as a theme at the World Economic Forum in Davos the same year. Coincidence.
2025: Kostaive — EU Approval Without Safety Review #
On February 14, 2025, Kostaive® (Arcturus Therapeutics / CSL Seqirus) receives EU approval. First sa-mRNA vaccine worldwide on the Western market.
Approved — despite ZKBS (Berlin) and COGEM (The Hague) warning jointly in an open letter: no environmental risk assessment conducted, possible transmission to third parties unresolved, long-term effects unknown.
The EU ignored it. Details in Part 3.
2026: Autumn Campaign Ready #
Dutch Health Council: new COVID vaccination recommendation for autumn 2026 using mRNA vaccines.
Kostaive: the only approved sa-mRNA product.
Infrastructure: ready.
The Complete Circle #
2011: Epstein/Gates/JPMorgan → "more money for vaccines", vaccines as capital strategy
↓
2017: CEPI founded (Gates + WEF) → goal: vaccines in <1 year
↓
2022: Gates Foundation → $300M to CEPI
↓
2023: CEPI → funds sa-mRNA for "Disease X"
↓
2025: Kostaive → EU approval without ERA, warnings ignored
↓
2026: Autumn campaign plannedThis is not a coincidence. This is an investment with expected returns.
What This Means #
The Epstein Files showed: pandemics were treated as standing investment categories. Parametric reinsurance products automatically pay out when epidemiological thresholds are reached. Impact investment funds promise 5–7% returns on vaccines.
Whoever invested in these structures benefits from pandemics being declared emergencies — and from new vaccines being rapidly approved and broadly deployed.
Kostaive is not the end product. It is the new platform. Sa-mRNA today, trans-amplifying mRNA tomorrow. The market grows with every new technology tier.
And CEPI is already standing by with the next one.
What Remains #
Wiesendanger put it in Part 2: “It was never about the health of the population.”
Sayer Ji documented it in Part 1: The structures were ready before COVID. Capital vehicles, legal frameworks, simulations, reinsurance products.
And now the end product is here: a self-amplifying vaccine, funded by the same networks, approved without environmental review, for a campaign already planned for autumn 2026.
The circle is closed.
Sources:
- CEPI/Gates $300M: Wikipedia CEPI
- CEPI sa-mRNA Disease X funding: cepi.net
- CEPI trans-amplifying mRNA: cepi.net
- EMA Kostaive EU approval: ema.europa.eu
- Epstein/Gates/JPMorgan documents: epsteinfilez.com — EFTA01860211